Abstract
The invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same.
Full Text
What is claimed is:
The invention provides programmed death-ligand 1 (PD-L1) antibodies and methods of using the same.
Timeline
Filed
04/16/2026Published
08/06/2026Granted
Not AvailableIPC Codes(7)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 39/395:Antibodies (agglutinins A61K 38/36); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61K 45/06:Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca